EMJ Diabetes
@EMJDiabetes
Followers
3K
Following
1K
Statuses
11K
EMJ: #1 open access destination for HCPs & Pharma globally. Peer-reviewed journals & diverse content hub. Interviews, podcasts, webinars, infographics.
United Kingdom
Joined December 2013
📖 The latest issue of EMJ Diabetes is out now! We are thrilled to share the 11th edition of EMJ Diabetes with you, including highlights from #EASD2023, and peer-reviewed articles. Download for free here 👉 #MedicalJournal #Diabetes #OpenAccess
0
0
1
Can exercise protect your brain? New research shows that workouts may improve cognition by enhancing how the brain responds to insulin. Dive into the details:
0
0
0
Curious to know which news story HCPs were reading the most in January? A groundbreaking stem cell therapy has enabled a 25-year-old woman in China with Type 1 diabetes to remain insulin-free for over a year—using her own fat cells. Read more:
0
0
0
Could GLP1RA medications, taken for for managing Type 2 diabetes and obesity, impact mood, anxiety, or risk-taking? New research explores surprising genetic insights beyond their metabolic benefits. Read more:
0
0
0
We are searching for engaging and dynamic podcast hosts. You’ll be at the forefront of shaping conversations that inspire, educate and help elevate the quality of care globally amongst HCP's. Apply today or share with your network!
0
0
0
New research shows continuous glucose monitors can predict diabetes-related risks, potentially transforming patient outcomes. Read more:
0
0
0
How does your gut influence sugar cravings? New research reveals the role of the gut receptor Ffar4 in sugar preference and metabolic health. Read more:
0
0
3
A recent study examined the impact of certain diets on gut health and metabolic outcomes in patients with Type 2 diabetes or obesity. Explore the findings:
0
0
0
We're on the hunt for dynamic and engaging podcast hosts. You’ll be at the forefront of shaping conversations that inspire, educate and help elevate the quality of care globally amongst HCP's. apply below or share with your network!
0
0
0
A new trial shows insulin remains the gold standard for gestational diabetes, outperforming metformin and glyburide in key outcomes. Read more:
0
0
0
A new study has highlighted a promising therapeutic target for diabetic cardiomyopathy. Discover more:
0
0
0
A study has identified a promising treatment for diabetes induced heart disease. Read here:
0
0
0
Researchers have uncovered a vital function of an insulin-inhibitory receptor, which could revolutionise diabetes treatment. Learn more:
0
0
0
How are GLP-1 drugs easing the burden of chronic disease? Find out in the latest EMJ Podcast episode. Join guest Martin Whyte as he chats with Jonathan about the prevalence and management of NAFLD, breakthroughs in managing PCOS and more. Tune in here:
0
0
0
A study has revealed global diabetes rates have doubled from 7% in 1990 to 14% in 2022, but what is causing this rise? Read the full study:
0
0
0
Discover the latest developments in diabetes treatment and care at the @IntDiabetesFed World Diabetes Congress 2025, 7-10 April in Bangkok, Thailand. 👉 Take advantage of the early registration rate before 29 November to save up to 30%!
0
0
0
Limiting sugar intake during early life, including in utero, may significantly reduce the risk of developing Type 2 diabetes, new research suggests. Read the full study: #Diabetes #MedicalResearch
0
0
0
New research has demonstrated the benefits of bariatric surgery in young patients. Read the study: #Healthcare #Diabetes
0
0
0
This World Diabetes Day, discover what led Francesco Giorgino, Senior Vice President, @EASDnews into a career in the diabetes space, his interest in the mechanisms of insulin resistance, and much more. Read his interview here:
0
1
1
A Japan-based team has made strides in improving non-invasive blood glucose monitoring technology. Learn more:
0
0
0
Researchers have developed an AI tool that could help detect signs of Type 1 diabetes in children before they experience complications. Learn more: #Diabetes #DiabetesResearch
0
0
0